Emerging Markets to Drive the Growth of Biopharmaceuticals in the Next Five Years
According to Imarc’s latest research report, “Global Biopharmaceutical Market Report (2010-2015)”, biopharmaceutical sales in the seven emerging markets- Russia, China, Turkey, Mexico, South Korea, India and Brazil will more than triple from the current US$ 4.5 billion to more than US$ 13.6 billion by 2015.
Monoclonal Antibodies: A Gold Rush Among Drug Manufacturers
"The commercial success achieved by Monoclonal Antibodies in the last five years cannot be matched by any other drug class. Imarc expects this robust growth to continue in the next five years, driven primarily by a rich late stage pipeline and a strong demand from patients having high unmet therapeutic needs."